Foghorn Therapeutics Inc. Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax
Foghorn Therapeutics Inc. (FHTX) had Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax of $134.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss
us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax · last filed 2026-08-06
- 2026-06-30: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax $134.00K.
- 2026-03-31: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax $133.00K.
- 2025-12-31: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax $3.00K.
- 2025-09-30: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax $4.00K.
| Period end | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax |
|---|---|
| 2026-06-30 | $134.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $133.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $3.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $4.00K 10-Q · filed 2025-11-05 |
| 2025-06-30 | $58.00K 10-Q · filed 2025-08-05 |
| 2025-03-31 | $37.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $40.00K 10-K · filed 2026-03-11 |
| 2024-09-30 | $25.00K 10-Q · filed 2024-11-04 |
| 2024-06-30 | $338.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $502.00K 10-Q · filed 2024-05-06 |
| 2023-12-31 | $844.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | $1.89M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $2.72M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $2.88M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $3.99M 10-K · filed 2024-03-07 |
| 2022-09-30 | $4.87M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $3.19M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $1.20M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $10.00K 10-K · filed 2023-03-09 |
| 2021-09-30 | $13.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $10.00K 10-Q · filed 2021-08-10 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-11 |
| 2020-12-31 | $7.00K 10-K/A · filed 2022-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |